213 related articles for article (PubMed ID: 29396474)
21. Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.
Nehme Z; Pasquereau S; Haidar Ahmad S; El Baba R; Herbein G
EBioMedicine; 2022 Jun; 80():104056. PubMed ID: 35596973
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
[TBL] [Abstract][Full Text] [Related]
23. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
Cheng T; Xu Y
Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
[TBL] [Abstract][Full Text] [Related]
24. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
[TBL] [Abstract][Full Text] [Related]
25. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
Li Z; Wang D; Lu J; Huang B; Wang Y; Dong M; Fan D; Li H; Gao Y; Hou P; Li M; Liu H; Pan ZQ; Zheng J; Bai J
Cell Death Differ; 2020 Dec; 27(12):3226-3242. PubMed ID: 32895488
[TBL] [Abstract][Full Text] [Related]
26. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
27. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
28. Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors.
Shih YL; Liu HC; Chen CS; Hsu CH; Pan MH; Chang HW; Chang CH; Chen FC; Ho CT; Yang YY; Ho YS
J Agric Food Chem; 2010 Jan; 58(1):235-41. PubMed ID: 19921817
[TBL] [Abstract][Full Text] [Related]
29. Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis.
Li Z; Wang D; Wang W; Chen X; Tang A; Hou P; Li M; Zheng J; Bai J
Biochem Biophys Res Commun; 2020 Dec; 533(4):679-684. PubMed ID: 33092789
[TBL] [Abstract][Full Text] [Related]
30. EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer.
Wu Q; Chen Z; Zhang G; Zhou W; Peng Y; Liu R; Chen C; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):693-700. PubMed ID: 29790898
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.
Ye L; Li F; Song Y; Yu D; Xiong Z; Li Y; Shi T; Yuan Z; Lin C; Wu X; Ren L; Li X; Song L
Int J Cancer; 2018 Nov; 143(10):2602-2613. PubMed ID: 30151890
[TBL] [Abstract][Full Text] [Related]
32. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
Ihira K; Dong P; Xiong Y; Watari H; Konno Y; Hanley SJ; Noguchi M; Hirata N; Suizu F; Yamada T; Kudo M; Sakuragi N
Oncotarget; 2017 Feb; 8(8):13509-13520. PubMed ID: 28088786
[TBL] [Abstract][Full Text] [Related]
33. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
Forma E; Jóźwiak P; Ciesielski P; Zaczek A; Starska K; Bryś M; Krześlak A
PLoS One; 2018; 13(6):e0198351. PubMed ID: 29864144
[TBL] [Abstract][Full Text] [Related]
34. miR‑92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2.
Liu F; Sang M; Meng L; Gu L; Liu S; Li J; Geng C
Int J Oncol; 2018 Oct; 53(4):1505-1515. PubMed ID: 30066891
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.
Yu P; Guo Y; Yusufu M; Liu Z; Wang S; Yin X; Peng G; Wang L; Zhao X; Guo H; Huang T; Liu C
Cell Biol Int; 2016 Oct; 40(10):1062-70. PubMed ID: 27436059
[TBL] [Abstract][Full Text] [Related]
36. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells.
Lee CH; Huang CS; Chen CS; Tu SH; Wang YJ; Chang YJ; Tam KW; Wei PL; Cheng TC; Chu JS; Chen LC; Wu CH; Ho YS
J Natl Cancer Inst; 2010 Sep; 102(17):1322-35. PubMed ID: 20733118
[TBL] [Abstract][Full Text] [Related]
37. PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis.
Li Z; Wang D; Chen X; Wang W; Wang P; Hou P; Li M; Chu S; Qiao S; Zheng J; Bai J
Cell Death Dis; 2021 Nov; 12(11):1080. PubMed ID: 34775498
[TBL] [Abstract][Full Text] [Related]
38. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
39. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.
Bihani T; Ezell SA; Ladd B; Grosskurth SE; Mazzola AM; Pietras M; Reimer C; Zinda M; Fawell S; D'Cruz CM
Oncotarget; 2015 Feb; 6(4):2407-20. PubMed ID: 25537515
[TBL] [Abstract][Full Text] [Related]
40. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
